May 25th, 2022 (Earnings Report)Dear Reader,
HealthTechMovers.com just identified several healthtech stocks that are expected to release earnings starting today, May 25th.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Abbott Labs
Symbol: ABT
Recent Price: $100.91
Average Analyst Price Target: $123.08 (21.97%)
Last Year's EPS: $1.4
Consensus EPS Forecast: $0.95
Expected Earnings Date: Oct 18 2022
Recent Analyst Action: Matthew Taylor, analyst at Jefferies, reiterates coverage on Abbott Labs (ABT) in the Healthcare sector with a Hold rating and a price target of $ 110 (2 days ago).
Click for complete article >>--------------------------------------------------------------------------
Brainstorm Cell Therapeutics
Symbol: BCLI
Recent Price: $3.48
Average Analyst Price Target: $8.00 (129.89%)
Last Year's EPS: -$0.15
Consensus EPS Forecast: -$0.18
Expected Earnings Date: Oct 18 2022
Recent Analyst Action: Jason McCarthy, analyst at Maxim Group, reiterates coverage on Brainstorm Cell Therapeutics (BCLI) in the Healthcare sector with a Buy rating and a price target of $ 8 (4 weeks ago).
Click for complete article >>--------------------------------------------------------------------------
Elevance Health
Symbol: ELV
Recent Price: $470.77
Average Analyst Price Target: $549.70 (16.77%)
Last Year's EPS: $6.79
Consensus EPS Forecast: $7.15
Expected Earnings Date: Oct 18 2022
Recent Analyst Action: Kevin Fischbeck, analyst at Bank of America Securities, reiterates coverage on Elevance Health (ELV) in the Healthcare sector with a Buy rating and a price target of $ 575 (1 month ago).
Click for complete article >>--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com
